• 60 Degrees Pharmaceuticals issued a correction to a prospectus supplement after identifying an error in the reported common shares beneficially owned by a company affiliate.
• The affiliate’s beneficial ownership was revised to 23,367 shares from 21,490 shares.
• The company said the error originated from an incorrect total share amount in a Form 4 filed on September 15, 2025, which was carried forward into later filings.
• The corrected total beneficial ownership after the 1-for-4 reverse stock split was stated as 16,781 shares rather than 15,905 shares.
• It said no other information in the prospectus supplement was affected by the correction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-032352), on March 20, 2026, and is solely responsible for the information contained therein.